Research Use Recombinant Protein Market to Reach $1.55 Billion by 2031
The market for recombinant proteins used in research is projected to reach $1.55 billion by 2031, up from $1.11 billion in 2026. The market is expected to grow at a CAGR of 7.0%.
The market for recombinant proteins used in research is forecast to reach $1.55 billion by 2031, expanding from $1.11 billion in 2026. According to MarketsandMarkets™, this segment is expected to grow at a compound annual growth rate (CAGR) of 7.0% during the forecast period.
This growth is attributed to increased investment in life science research and development, a rising demand for biopharmaceuticals, and advancements in personalized medicine and diagnostics. Recombinant proteins are critical components in the development of these advanced therapies and diagnostic tools.
The market can be segmented by protein type, application, and end-user. Key protein types include growth factors, antibodies, and enzymes, while applications span protein function studies, drug discovery, and diagnostics. Academic research institutions and pharmaceutical companies represent the primary end-users.
Future expansion of the market is anticipated as novel research methodologies and technologies continue to emerge. Applications in personalized medicine and cell biology are expected to be significant drivers of demand.